UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease

Journal of thrombosis and haemostasis, 2014-09, Vol.12 (9), p.1494-1502

2014

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug

Medical & biological engineering & computing, 2023-07, Vol.61 (7), p.1697-1722

2023

Volltextzugriff (PDF)

Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials

Diabetes & metabolism, 2017-02, Vol.43 (1), p.48-58

2017

Volltextzugriff (PDF)

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases

Seminars in arthritis and rheumatism, 2020-12, Vol.50 (6), p.1307-1313

2020

Volltextzugriff (PDF)

[OP.4A.03] PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e34-e35

2017

Volltextzugriff (PDF)

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?

Diabetes & metabolism, 2014-06, Vol.40 (3), p.169-175

2014

Volltextzugriff (PDF)

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis

Thrombosis research, 2021-01, Vol.197, p.24-32

2021

Volltextzugriff (PDF)

Corrigendum to “Abstracts Presented at EACPT 2017”: Clin Ther 2017;39:e66

Clinical therapeutics, 2017-08, Vol.39 (8), p.1748-1748

2017

Volltextzugriff (PDF)

Risk Reduction or Treat-To-Target Strategy? Economic Assessment of Statin use in Cardiovascular Prevention

Clinical therapeutics, 2017-08, Vol.39 (8), p.e66-e66

2017

Volltextzugriff (PDF)

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

Diabetes & metabolism, 2015-06, Vol.41 (3), p.195-201

2015

Volltextzugriff (PDF)

[OP.3B.01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e28-e28

2017

Volltextzugriff (PDF)

Multivariate meta-analysis using individual participant data

Research synthesis methods, 2015-06, Vol.6 (2), p.157-174

2015

Volltextzugriff (PDF)

Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change

Journal of human hypertension, 2014-01, Vol.28 (1), p.68-70

2014

Volltextzugriff (PDF)

[OP.1A.06] DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e2-e3

2017

Volltextzugriff (PDF)

How individual participant data meta-analyses have influenced trial design, conduct, and analysis

Journal of clinical epidemiology, 2015-11, Vol.68 (11), p.1325-1335

2015

Volltextzugriff (PDF)

Efficiency of physical therapy on postural imbalance after stroke: study protocol for a systematic review and meta-analysis

BMJ open, 2017-01, Vol.7 (1), p.e013348-e013348

2017

Volltextzugriff (PDF)

New insights on the Pioglitazone risk-benefit ratio in European Population

Clinical therapeutics, 2015-08, Vol.37 (8), p.e16-e17

2015

Volltextzugriff (PDF)

PP084—A European score predicts better south american cardiovascular risk than framingham risk equations

Clinical therapeutics, 2013-08, Vol.35 (8), p.e44-e44

2013

Volltextzugriff (PDF)

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis

Diabetes & metabolism, 2019-12, Vol.45 (6), p.550-556

2019

Volltextzugriff (PDF)

[OP.1D.08] SYNERGETIC PREVENTION OF SUDDEN DEATH BY ACEI, STATIN AND GLIFLOZIN IN TYPE 2 DIABETES: A SIMULATION STUDY

Journal of hypertension, 2016-09, Vol.34 Suppl 2 - ESH 2016 Abstract Book (Supplement 2), p.e13-e14

2016

Volltextzugriff (PDF)

Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial

Journal of human hypertension, 2015-01, Vol.29 (1), p.22-27

2015

Volltextzugriff (PDF)

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

BMJ, 2001-07, Vol.323 (7304), p.75-81

International edition, 2001

Volltextzugriff (PDF)

Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock

In silico biology, 2020-07, Vol.14 (1-2), p.101-121

2020

Volltextzugriff (PDF)

Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: A randomised study

The Journal of nutrition, health & aging, 2012-04, Vol.16 (4), p.370-377

2012

Volltextzugriff (PDF)

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

BMJ, 2011-07, Vol.343 (7817), p.d4169-d4169

International edition, 2011

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(103)
Science & Technology
(88)
Life Sciences & Biomedicine
(81)
Life Sciences
(57)
Female
(38)
Male
(37)
Hypertension - Drug Therapy
(35)
Biological And Medical Sciences
(31)
Medical Sciences
(30)
Middle Aged
(28)
Risk Factors
(28)
Treatment Outcome
(27)
Cardiovascular System & Cardiology
(26)
Aged
(25)
Antihypertensive Agents - Therapeutic Use
(25)
Meta-Analysis
(24)
Randomized Controlled Trials As Topic
(21)
Clinical Trials
(20)
Hypertension
(19)
Peripheral Vascular Disease
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease

Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug

Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases

[OP.4A.03] PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis

Corrigendum to “Abstracts Presented at EACPT 2017”: Clin Ther 2017;39:e66

Risk Reduction or Treat-To-Target Strategy? Economic Assessment of Statin use in Cardiovascular Prevention

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

[OP.3B.01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION

Multivariate meta-analysis using individual participant data

Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change

[OP.1A.06] DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA

How individual participant data meta-analyses have influenced trial design, conduct, and analysis

Efficiency of physical therapy on postural imbalance after stroke: study protocol for a systematic review and meta-analysis

New insights on the Pioglitazone risk-benefit ratio in European Population

PP084—A European score predicts better south american cardiovascular risk than framingham risk equations

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis

[OP.1D.08] SYNERGETIC PREVENTION OF SUDDEN DEATH BY ACEI, STATIN AND GLIFLOZIN IN TYPE 2 DIABETES: A SIMULATION STUDY

Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial

A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials

Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock

Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: A randomised study

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Suchergebnisse filtern